wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36709649-AB0045D3-FF8F-4E4E-8192-0B0CB33CAD3D
Q36709649-AB0045D3-FF8F-4E4E-8192-0B0CB33CAD3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36709649-AB0045D3-FF8F-4E4E-8192-0B0CB33CAD3D
Redefining response in overactive bladder syndrome.
P2860
Q36709649-AB0045D3-FF8F-4E4E-8192-0B0CB33CAD3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36709649-AB0045D3-FF8F-4E4E-8192-0B0CB33CAD3D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f66a492b1f3b67144a741637a0217f31438b769
P2860
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.